Girard R, Pedron T, Kosma P, Chaby R
Infect Immun. 1993; 61(9):3616-24.
PMID: 7689537
PMC: 281056.
DOI: 10.1128/iai.61.9.3616-3624.1993.
Rastogi S, Clausen J
Clin Exp Immunol. 1980; 42(1):50-6.
PMID: 7006875
PMC: 1537075.
Wrigley D, Saluk P
Infect Immun. 1981; 34(3):780-6.
PMID: 6977491
PMC: 350939.
DOI: 10.1128/iai.34.3.780-786.1981.
Granelli-Piperno A, Vassalli J, Reich E
J Exp Med. 1981; 154(2):422-31.
PMID: 6973604
PMC: 2186437.
DOI: 10.1084/jem.154.2.422.
Schnyder J, Baggiolini M
Proc Natl Acad Sci U S A. 1980; 77(1):414-7.
PMID: 6928634
PMC: 348281.
DOI: 10.1073/pnas.77.1.414.
Fate of Listeria monocytogenes in murine peritoneal macrophage subpopulations.
Wilder M
Infect Immun. 1982; 35(1):124-32.
PMID: 6797945
PMC: 351005.
DOI: 10.1128/iai.35.1.124-132.1982.
Recombinant human gamma-interferon induces human monocyte polykaryon formation.
Weinberg J, Hobbs M, Misukonis M
Proc Natl Acad Sci U S A. 1984; 81(14):4554-7.
PMID: 6431409
PMC: 345629.
DOI: 10.1073/pnas.81.14.4554.
Suppression of the neutral protease activity of macrophages treated with asbestos in vitro.
Hamilton J
Environ Health Perspect. 1983; 51:103-8.
PMID: 6416822
PMC: 1569311.
DOI: 10.1289/ehp.8351103.
The role of lymphokines in delayed-type hypersensitivity reactions.
Geczy C
Springer Semin Immunopathol. 1984; 7(4):321-46.
PMID: 6395409
DOI: 10.1007/BF00201965.
Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
Vassalli J, Dayer J, Wohlwend A, Belin D
J Exp Med. 1984; 159(6):1653-68.
PMID: 6374011
PMC: 2187313.
DOI: 10.1084/jem.159.6.1653.
Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
Chapman Jr H, Stone O, Vavrin Z
J Clin Invest. 1984; 73(3):806-15.
PMID: 6368589
PMC: 425084.
DOI: 10.1172/JCI111275.
T-independent macrophage changes in murine malaria.
Lelchuk R, Dockrell H, Playfair J
Clin Exp Immunol. 1983; 51(3):487-93.
PMID: 6342882
PMC: 1536773.
Macrophage-related fibrinolysis in experimental disseminated histoplasmosis.
Tiku M, McNabb P, TOMASI Jr T
Infect Immun. 1985; 49(3):641-6.
PMID: 3875559
PMC: 261231.
DOI: 10.1128/iai.49.3.641-646.1985.
A lymphokine regulates expression of alpha-1-proteinase inhibitor in human monocytes and macrophages.
Takemura S, Rossing T, Perlmutter D
J Clin Invest. 1986; 77(4):1207-13.
PMID: 3485658
PMC: 424458.
DOI: 10.1172/JCI112423.
T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.
Emeson E, ROBERTSON Jr A
Am J Pathol. 1988; 130(2):369-76.
PMID: 3257650
PMC: 1880529.
Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
Dong Q, Zhou M, Subbarao V, Tsao C
Br J Exp Pathol. 1988; 69(5):685-95.
PMID: 3143395
PMC: 2013274.
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C, Kruithof E, Schleuning W
J Cell Biol. 1987; 104(3):705-12.
PMID: 3102504
PMC: 2114546.
DOI: 10.1083/jcb.104.3.705.
Influence of hypercholesterolemia and cholesterol accumulation on rabbit carrageenan granuloma macrophage activation.
Kelley J, Suenram C, Rozek M, Schwartz C
Am J Pathol. 1988; 131(3):539-46.
PMID: 2837904
PMC: 1880697.
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
Wohlwend A, Belin D, Vassalli J
J Exp Med. 1987; 165(2):320-39.
PMID: 2434595
PMC: 2188521.
DOI: 10.1084/jem.165.2.320.
Modulation of mannose receptor activity by proteolysis.
Shepherd V, Abdolrasulnia R, Stephenson J, CRENSHAW C
Biochem J. 1990; 270(3):771-6.
PMID: 2241909
PMC: 1131799.
DOI: 10.1042/bj2700771.